| Literature DB >> 33803721 |
Sebastian Simon1,2, Bernhard J H Frank1, Alexander Aichmair1,2, Philip P Manolopoulos1, Martin Dominkus2,3, Eva S Schernhammer4, Jochen G Hofstaetter1,2.
Abstract
The aim of this study was to evaluate the number of primary and revision total joint arthroplasties (TJA/rTJA) in 2020 compared to 2019. Specifically, the first and the second waves of the COVID-19 pandemic were evaluated as well as the pre-operative COVID-19 test. A cross-sectional single-center study of our prospectively maintained institutional arthroplasty registry was performed. The first COVID-19 wave and the second COVID-19 wave led to a socioeconomic lockdown in 2020. Performed surgeries, cause of revision, age, gender, and American Society of Anesthesiologists-level were analyzed. Preoperative COVID-19 testing was evaluated and nationwide COVID-19 data were compared to other countries. In 2020, there was a decrease by 16.2% in primary and revision TJAs of the hip and knee compared to 2019. We observed a reduction of 15.8% in primary TJAs and a reduction of 18.6% on rTJAs in 2020 compared to 2019. There is an incline in total hip arthroplasties (THAs) and a decline in total knee arthroplasties (TKAs) comparing 2019 to 2020. During the first wave, there was a reduction in performed primary TJAs of 86%. During the second wave, no changes were observed. This is the first study quantifying the impact of the COVID-19 pandemic on primary and revision TJAs regarding the first and second wave.Entities:
Keywords: COVID-19; hip and knee arthroplasty; pandemic impact
Year: 2021 PMID: 33803721 PMCID: PMC8003209 DOI: 10.3390/jcm10061260
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Figure 1COVID-19 cases and performed tests. (a): Daily new cases per 100,000 per calendar week for Austria (AUT), Germany (GER), Italy (ITA), the UK, and the USA. The grey shaded areas visualize the first and the second wave in Austria. (b): Absolute number of performed and positive tests in our center per calendar week. The grey shaded areas visualize the first and the second wave in Austria.
Figure 2COVID-19 deaths and relative number of performed primary and revision total joint arthroplasties (TJAs). (a): Relative number of COVID-19 deaths in Austria per age group. (b): Relative number of primary and revision total joint arthroplasties (TJAs) per age group.
Figure 3Number of performed primary and revision total joint arthroplasties. (a): Absolute numbers of primary TJAs per calendar week, comparing 2019 and 2020. The grey shaded areas visualize the first and the second wave in Austria. (b): Absolute numbers of primary TJAs per calendar week, comparing 2019 and 2020. The grey shaded areas visualize the first and the second wave in Austria. (c): Ratio between the numbers of revision and primary TJAs per calendar week, comparing 2019 and 2020. The grey shaded areas visualize the first and the second wave in Austria.
Characteristics of study relevant parameters for surgical procedures in 2019 and 2020 including gender, age, and American Society of Anaesthesiologists (ASA)-level. Frequencies and column percentage of distribution according occurrence of septic, aseptic loosening, Instability/Dislocation, fracture, other septic conditions, abrasion, pain, implant failure, and leg length difference (LLD); ** p ≤ 0.01, * p ≤ 0.05.
| Parameter | 2019 | 2020 | |
|---|---|---|---|
|
|
|
| |
| Primary TJAs total | 2457 (85.7%) | 2069 (86.1%) | 0.672 |
| Gender female | 1552 (63.2%) | 1330 (64.3%) | 0.309 |
| male | 905 (36.8%) | 739 (35.7%) | |
| Age | 68.1 (±11.4) | 68.2 (±11.3) | 0.360 |
| ASA-level | 1.97 (±0.46) | 1.96 (±0.47) | 0.420 |
| Revision TJAs total | 409 (14.3%) | 333 (13.9%) | 0.672 |
| Gender female | 247 (60.4%) | 191 (57.4%) | 0.923 |
| male | 162 (39.6%) | 142 (42.6%) | |
| Age | 69.3 (±11.7) | 68.5 (±12.7) | 0.485 |
| ASA-level | 2.21 (±0.53) | 2.02 (±0.46) | <0.001 ** |
|
|
|
| |
| Primary TKAs | 1272 (86.1%) | 956 (83.3%) | 0.049 * |
| Gender female | 827 (65.0%) | 620 (64.9%) | 0.937 |
| male | 445 (35.0%) | 336 (35.1%) | |
| Age (years) | 69.6 (±9.5) | 69.6 (±9.7) | 0.751 |
| ASA-level | 2.02 (±0.42) | 2.01 (±0.41) | 0.642 |
| Revision TKAs | 205 (13.9%) | 191 (16.7%) | 0.049 * |
| Gender female | 123 (60.0%) | 114 (59.7%) | 0.915 |
| male | 82 (40.0%) | 77 (40.3%) | |
| Age (years) | 71.2 (±9.5) | 69.9 (±10.7) | 0.320 |
| ASA-level | 2.18 (±0.44) | 2.07 (±0.41) | 0.048 * |
| Cause of Revision TKAs | |||
| Septic | 95 (46.3%) | 88 (46.1%) | 0.519 |
| Instability | 35 (17.1%) | 33 (17.3%) | 0.957 |
| Pain | 16 (7.8%) | 24 (13.0%) | 0.748 |
| Aseptic loosening | 28 (13.7%) | 21 (11.0%) | 0.276 |
| Fracture | 6 (2.9%) | 8 (4.2%) | 0.252 |
| Other aseptic | 14 (6.8%) | 8 (4.2%) | 0.687 |
| Wear | 7 (3.4%) | 5 (2.6%) | 0.852 |
| Implant Failure | 4 (2.0%) | 4 (2.1%) | 0.919 |
|
|
|
| |
| Primary THAs | 1185 (85.3%) | 1113 (88.7%) | 0.010 ** |
| Gender female | 725 (61.2%) | 710 (63.8%) | 0.197 |
| male | 460 (38.8%) | 403 (36.2%) | |
| Age (years) | 66.4 (±12.9) | 66.8 (±12.4) | 0.582 |
| ASA-level | 1.92 (±0.50) | 1.91 (±0.51) | 0.715 |
| Revision THAs | 204 (14.7%) | 142 (11.3%) | 0.010 ** |
| Gender female | 124 (60.8%) | 90 (63.4%) | 0.625 |
| male | 80 (39.2%) | 52 (36.6%) | |
| Age (years) | 67.4 (±13.3) | 66.6 (±14.9) | 0.320 |
| ASA-level | 2.23 (±0.60) | 1.97 (±0.51) | 0.001 ** |
| Cause of Revision THAs | |||
| Septic | 95 (46.6%) | 43 (30.3%) | 0.002 ** |
| Aseptic loosening | 50 (24.5%) | 52 (36.6%) | 0.015 * |
| Dislocation | 26 (12.7%) | 24 (16.9%) | 0.279 |
| Fracture | 14 (6.8%) | 16 (11.3%) | 0.152 |
| Other aseptic | 4 (2.9%) | 2 (1.4%) | 0.699 |
| Wear | 2 (1.0%) | 2 (1.4%) | 0.714 |
| Pain | 2 (1.0%) | 1 (0.7%) | 0.146 |
| Implant Failure | 4 (2.0%) | 1 (0.7%) | 0.221 |
| LLD | 2 (1.0%) | 1 (0.7%) | 0.785 |
TJA, total joint arthroplasty; THA, total hip arthroplasty; TKA, total knee arthroplasty.